Axa
CDMO

Axa’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Axa’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-21,956
Closed -$93K – 1375
2019
Q1 		$93K Buy
+21,956
New +$89.6K ﹤0.01% 1296
2018
Q3 		– Sell
-48,900
Closed -$192K – 1403
2018
Q2 		$192K Sell
48,900
-34,800
-42% -$121K ﹤0.01% 1305
2018
Q1 		$244K Hold
83,700
– – ﹤0.01% 1294
2017
Q4 		$325K Buy
83,700
+2,000
+2% +$8.57K ﹤0.01% 1221
2017
Q3 		$257K Buy
+81,700
New +$307K ﹤0.01% 1234

Other funds holding CDMO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Axa's CDMO Position: Q2 2019 in Review

Axa sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2019, closing a stake of 21,956 shares — an estimated $93K sold.

Axa first reported a position in CDMO in Q3 2017 and held it in 5 quarters. The position peaked at $325K in Q4 2017. 98 funds tracked by Wall St. Rank hold CDMO as of Q2 2019.

  • Axa reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Axa sold 21,956 Avid Bioservices, Inc. Common Stock shares in Q2 2019, an estimated $93K.
  • Axa first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2017 and held it in 5 quarters.
  • Axa's Avid Bioservices, Inc. Common Stock position peaked at $325K in Q4 2017.
  • 98 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2019.

Based on Axa's 13F filing for Q2 2019, filed 13 Aug 2019.